MedPath

Comparison of the effect of aromatherapy and edible rose essential oil on saliva cortisol level and quality of life of chronic renal failure patients undergoing hemodialysis

Early Phase 1
Conditions
Patients with chronic renal failure under hemodialysis.
Chronic kidney disease, stage 5
N18.5
Registration Number
IRCT20200610047725N1
Lead Sponsor
Yasouj University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
72
Inclusion Criteria

Ability to communicate and answer questions
Consent to participate in the study and sign the informed consent form
Healthy sense of smell
Not having an anxiety disorders
Not having a history of using aromatherapy
Not having asthma and allergies
Not brushing teeth
At least three months have passed since hemodialysis
Doing dialysis at least 2 to 3 times a week
Not taking corticosteroids and immunosuppressants
Not having active infection
Not having a history of organ transplant rejection
Dialysis in the morning shift
No history of cancer

Exclusion Criteria

Allergy to Rosa damascene and patient reaction to it
Taking anti-anxiety and anti-depressant drugs
Performing a kidney transplant during the study
Change of dialysis method from hemodialysis to peritoneal dialysis during the intervention
Hospitalization in the intensive care unit during the intervention

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Salivary cortisol levels. Timepoint: Salivary cortisol levels at the beginning of the study (before the intervention) and one month later. Method of measurement: By ELISA kits.;Quality of life. Timepoint: Quality of life at the beginning of the study (before the intervention) and one month later. Method of measurement: Kidney Disease Quality of Life-Short Form (KDQOL-SF) questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath